Canoe Financial LP Has $69.51 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Canoe Financial LP boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 226,952.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 231,594 shares of the company’s stock after purchasing an additional 231,492 shares during the quarter. Canoe Financial LP’s holdings in HCA Healthcare were worth $69,513,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of HCA. American Century Companies Inc. grew its holdings in HCA Healthcare by 60.0% in the second quarter. American Century Companies Inc. now owns 23,024 shares of the company’s stock worth $7,397,000 after purchasing an additional 8,633 shares during the period. Dimensional Fund Advisors LP increased its position in HCA Healthcare by 2.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 520,835 shares of the company’s stock valued at $167,426,000 after buying an additional 11,861 shares in the last quarter. Renaissance Technologies LLC acquired a new stake in HCA Healthcare in the second quarter valued at approximately $4,112,000. Blair William & Co. IL raised its position in shares of HCA Healthcare by 11.8% during the second quarter. Blair William & Co. IL now owns 9,464 shares of the company’s stock worth $3,041,000 after purchasing an additional 998 shares during the period. Finally, Seven Eight Capital LP acquired a new stake in HCA Healthcare in the 2nd quarter valued at $397,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

NYSE:HCA opened at $310.60 on Friday. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The company has a market capitalization of $78.68 billion, a P/E ratio of 13.95, a P/E/G ratio of 1.03 and a beta of 1.64. HCA Healthcare, Inc. has a 1 year low of $278.50 and a 1 year high of $417.14. The business has a fifty day simple moving average of $317.56 and a two-hundred day simple moving average of $352.81.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were given a dividend of $0.66 per share. The ex-dividend date was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.85%. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Insider Activity at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on HCA shares. Truist Financial reduced their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their price objective for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. Morgan Stanley reduced their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Finally, TD Cowen cut their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $385.27.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.